Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.
Remedium Bio has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
Remedium Bio's investors include Eli Lilly, National Science Foundation, MicroVentures, Longevitytech.fund, Angel Star Ventures.
Remedium Bio is headquartered in Needham, United States.
Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.
Remedium Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Remedium Bio — Funding & Investors." VCBacked, May 18, 2026, https://www.vcbacked.co/company/remedium-bio. Accessed October 17, 2026.
VCBacked. (2026). Remedium Bio — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/remedium-bio
{{cite web |title=Remedium Bio — Funding & Investors |url=https://www.vcbacked.co/company/remedium-bio |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated